NONE OVERVIEW FINANCIAL DISCLOSURES UPDATE ON IDIOPATHIC PULMONARY FIBROSIS/IPF (UIP) FOR PATHOLOGISTS. IPF = Idiopathic UIP Radiologic UIP Path UIP

Size: px
Start display at page:

Download "NONE OVERVIEW FINANCIAL DISCLOSURES UPDATE ON IDIOPATHIC PULMONARY FIBROSIS/IPF (UIP) FOR PATHOLOGISTS. IPF = Idiopathic UIP Radiologic UIP Path UIP"

Transcription

1 UPDATE ON IDIOPATHIC PULMONARY FIBROSIS/IPF () FOR PATHOLOGISTS Thomas V. Colby, M.D. Professor of Pathology (Emeritus) Mayo Clinic Arizona FINANCIAL DISCLOSURES NONE OVERVIEW IPF Radiologic Dx Pathologic Dx IPF = Idiopathic Radiologic Path Pathologic IPF Radiologic 1

2 What is IPF?? : IPF is defined as a specific form of chronic, progessive fibrosing interstitial pneumonia of unknown cause, occurring primarily in older adults, limited to the lungs, and associated with the histopathologic and/or radiologic pattern of. Slide courtesy Luca Richeldi Am J Respir Crit Care Med 2011; 183: IPF Guidelines IPF Defined by SLBx Hncb * or HRCT Fibroblast focus Peripheral/basal honeycombing; little/no ground glass Am J Respir Crit Care Med 2011; 183:

3 What is?? is a pattern of lung injury that can be recognized radiologically and pathologically While there is considerable overlap between radiologic and pathologic it is NOT perfect and recognition of this fact is important for radiologists How does this affect the pathologist?? Pathologists are asked to interpret lung biopsies done in suspected cases of IPF. Because finally some treatment is available.. Pirfenidone and Nintedanib are not curative and do not reverse the disease; they slow the progression From Google 3

4 2011 DIAGNOSTIC ALGORITHM FOR IPF IPF Slide courtesy Luca Richeldi Suspected IPF Identifiable cause for ILD? (CTD, drugs, exposures,...) NO Chest HRCT MDD IPF / Not IPF Consistent with Inconsistent with Surgical lung biopsy Possible / Probable Non classifiable fibrosis YES Not Not IPF Am J Respir Crit Care Med 2011; 183: Radiologic/HRCT Diagnosis From Google images HRCT PATTERN DEFINITE DEFINITE POSSIBLE Slide courtesy Luca Richeldi Am J Respir Crit Care Med 2011; 183:

5 OUTLINE 1. Pathology of 2. Where does the pathology of intersect with the radiologic identification of?? 3. What are the differences between radiologic and pathologic?? 4. Why is this important?? Biopsies in suspected cases of IPF DECISIONS FOR THE PATHOLOGIST 1. Is it? (well established histologic criteria) 2. Is it in the setting of idiopathic pulmonary fibrosis (IPF)? pathologic features 1) Evidence of marked fibrosis/architectural distortion, +/ honeycombing in a predominantly subpleural/paraseptal distribution 2) Presence of patchy involvement of lung parenchyma by fibrosis 3) Presence of fibroblast foci 4) Absence of features against a diagnosis of suggesting an alternate diagnosis 5

6 Usual Interstitial Pneumonia () Dense scar, honeycombing Fibroblast foci : Clear evidence of chronic scarring and architectural destruction; patchy Normal area Uninvolved lung Scarring/Honeycombing Fibroblast foci Patchy; Often subpleural and paraseptal distribution Upper lobe Middle lobe Lower lobe In the same patient Note: Honeycombing is not always present! 6

7 Fibroblast foci Note the proximity to established scarring Fibroblast foci reflect active and ongoing injury and scarring but not specific to Fibroblast foci start as organizing pneumonia but don t resolve and add to the adjacent fibrosis. Case of /IPF Criteria for have changed Liebow (1969 in Frontiers of Pulmonary Radiololgy): Diffuse alveolar damage that progresses to organization and honeycombing Carrington (1978 in NEJM): Variegated structure from normal alveoli to endstage/honeycomb lesions, cellular infiltrates, epithelial metaplasias, focal airspace exudates Katzenstein (1985 in Human Pathology and 1988 in Chest): Fibroblast foci are recognized and subsequently are included in the current criteria for Late 1980s: Subpleural/paraseptal distribution emphasized 7

8 Which is/are fibroblast foci? Hyaline membranes of diffuse alveolar damage In a case of acute exacerbation of IPF Organizing pneumonia (intraluminal polyp) Note surrounding normal lung Decisions for the pathologist 1. Is it? (well established histologic criteria) 2. Is it in the setting of idiopathic pulmonary fibrosis (IPF)?? IPF What else causes a pattern histologically?? Chronic hypersensitivity pneumonitis IPF Connective tissue disease Familial pulmonary fibrosis Drug reactions Miscellaneous 8

9 Clues to not due to IPF: Chronic hypersensitivity pneumonitis: Clues: giant cells, granulomas, central/bridging fibrosis, peribronchiolar metaplasia (CT: upper zone disease, air trapping; Expusure history) Connective tissue disease Clues: germinal centers, mixed patterns, follicular bronchiolitis, pleuritis, few fibroblast foci (Serologic findings) Familial pulmonary fibrosis (Family history) Drug reactions (Drug history) Miscellaneous rare conditions (History) Morell et al in Lancet Resp Med 2013; Smith et al in J Clin Pathol 2013; 66: 896 Chronic HP and IPF Lancet Respir Med Nov;1(9): Up to 50% of patients diagnosed with IPF according to the 2011IPF Guidelines may have Chronic HP!! CASE PRESENTATION 69M with increasing dyspnea Lifelong nonsmoker Bilateral lower lobe infiltrates with honeycombing in the RLL; VATS biopsy perfomed Fibroblast foci Dense, patch scarring Fulfills criteria for 9

10 MORE TO THE CASE These are features against the diagnosis of /IPF Pt had had birds for years Dx: Chr. Hypersensitivity pneumonitis Organizing pneumonia Granulomas RA Often there are clues that a CTD is present Increased inflammation Fibr. focus Pathologic and Radiologic Differences Between Idiopathic and CTD-Related (Song JW et.al. Chest 2009; 136: 23) 10

11 Sjogren s RA Germinal Centers are the most common clue to a CTD Features against /IPF (Clues to alternative diagnoses) Hyaline membranes* Organizing pneumonia* Granulomas Marked interstitial inflammatory cell infiltrate away from honeycombing Predominant airway centered changes *Can be seen in acute exacerbation Airway centered changes Is this too much airway centered injury? We don t know! Typical area 11

12 Peribronchiolar Metaplasia (PBM) Dx: Chronic HP PBM is common finding Occurs in..(59%*)... But also Chronic HP and airway disease *AJSP 2005; 29: 948 Acute Exacerbation of IPF NATURAL HISTORY OF IPF DISEASE PROGRESSION RAPID PROGRESSIO N ACUTE WORSENING STABL E SLOW PROGRESSIO N Acute exacerbation of IPF is defined on the clinical, radiologic and functional findings, not pathologically Histologically one see background with superimposed acute injury, usually acute TIME or organizing DAD Slide courtesy Luca Richeldi Am J Respir Crit Care Med 2011; 183: (modified) 12

13 When do pathologists encounter Acute exacerbation of IPF?? At autopsy of patients with IPF On biopsies of patients with IPF when there is sudden deterioration On biopsies of patients with IPF when there is concern for pneumonia On biopsies when clinically occult IPF presents an acute ILD Sudden deterioration in patients with other chronic interstitial pneumonias: CTD/ILD, Chr. HP, fibrotic NSIP Acute exacerbation of IPF: Autopsy DAD Acute exacerbation of IPF: Biopsy 13

14 ACUTE EXACERBATION OF A CHRONIC INTERSTITIAL PNEUMONIA Can occur with a number of chronic IPs /IPF CVD-associated ILD Chronic hypersensitivity pneumonitis Nonspecific interstitial pneumonia 2017 Update on the CT and Pathology diagnosis of IPF** Updated pathology table uses /IPF /IPF pattern Probable /IPF pattern Indeterminate for /IPF pattern All four criteria. No features to suggest an alternative diagnosis EITHER honeycomb fibrosis only, OR a severe fibrosing process that fails to meet all criteria for definite /IPF No features to suggest an alternative diagnosis Evidence of a fibrosing process but show features more in favor of either a non- pattern, or in a setting other than IPF. Features most consistent with an alternative diagnosis (a) Non- pattern (b) pattern with ancillary features strongly suggesting an alternative diagnosis occurring in settings other than IPF is acknowledged ** Lynch D. Lancet Resp Med 2017 DEFINITE /IPF 1. Clear evidence of chronic scarring and architectural destruction 2. Evidence of active fibrosis as fibroblast foci 3. Typically patchy, subpleural or paraseptal 4. Absence of features suggesting an alternative diagnoses 14

15 PROBABLE : HONEYCOMBING ONLY 1. Clear evidence of chronic scarring and architectural destruction 2. Evidence of active fibrosis as fibroblast foci 3. Typically patchy, subpleural or paraseptal 4. Absence of features suggesting an alternative diagnoses Probable /IPF Diagnostic categories of on CT** /IPF CT pattern Probable /IPF CT pattern Indeterminate for /IPF CT pattern CT features most consistent with an alternative diagnosis CT distribution Basal (occasionally Basal and subpleural diffuse) and subpleural predominant. predominant. Distribution is often Distribution is often heterogeneous. heterogeneous. Variable or diffuse e.g. Upper lung predominance, subpleural sparing, extensive mosaic attenuation CT features Honeycombing. Reticular pattern traction bronchiectasis/ bronchiolectasis Absence of non features Reticular pattern with peripheral traction bronchiectasis/ bronchiolectasis No honeycombing. Absence of non features Evidence of fibrosis with some features suggestive of non pattern ** Lynch D. Lancet Resp Med 2017 Radiologic Pathologic Radiology: Inconsistent with Pathology: From: Yagihashi et al. Eur Respir J 2016; 47:

16 HRCT honeycombing Pathologic honeycombing ~ 3 mm. HRCT (from: Hansell DM et al. Fleischner Terms. Radiology 2008; 246:697) clustered cystic air spaces (between 3-10 mm in diameter but occasionally as large as 2.5 cm) which are usually subpleural and basal in distribution. Pathologic Pathologically microscopic honeycombing is also recognized; biopsies tend not to include the big honeycomb spaces PATHOLOGIC DIAGNOSIS OF INTERSTITIAL PNEUMONIAS The current dogma: Surgical/VATS lung biopsies required to recognize patterns, esp., NSIP Transbronchial occasionally useful with clinical-radiologic correlation (but not in /IPF) Transbronchial cryobiopsies may change the entire paradigm! -Architectural features as seen on SLBx can be appreciated Criteria for have changed Liebow (1969 in Frontiers of Pulmonary Radiololgy): Diffuse alveolar damage that progresses to organization and honeycombing Carrington (1978 in NEJM): Variegated structure from normal alveoli to endstage/honeycomb lesions, cellular infiltrates, epithelial metaplasias, focal airspace exudates Katzenstein (1985 in Human Pathology and 1988 in Chest): Fibroblast foci are recognized and subsequently are included in the current criteria for Late 1980s: Subpleural/paraseptal distribution emphasized. HRCT of the lung came along!! Late 1990s: is recognized on CT scans (primarily in the setting of IPF) 16

17 Histologic Diagnosis of Based on a pattern typically identified in a surgical lung biopsy (SLBx) Often found when HRCT suggests NSIP KEY POINTS: An HRCT finding of NSIP does not exclude /IPF can be found in cases where HRCT is inconsistent with or not (Eg. Chr HP) Radiologic Pathologic (HRCT honeycombing Pathologic honeycombing) SUMMARY The pathologic criteria of are well established as are the radiologic criteria but Pathologic HRCT And not all is IPF Pathologic IPF Radiologic 17

Usual Interstitial pneumonia and Nonspecific Interstitial Pneumonia. Nitra and the Gangs.

Usual Interstitial pneumonia and Nonspecific Interstitial Pneumonia. Nitra and the Gangs. Usual Interstitial pneumonia and Nonspecific Interstitial Pneumonia Nitra and the Gangs. บทน ำและบทท ๓, ๑๐, ๑๒, ๑๓, ๑๔, ๑๕, ๑๗ Usual Interstitial Pneumonia (UIP) Most common & basic pathologic pattern

More information

Non-neoplastic Lung Disease II

Non-neoplastic Lung Disease II Pathobasic Non-neoplastic Lung Disease II Spasenija Savic Prince Pathology Program Systematic approach to surgical lung biopsies with ILD Examples (chronic ILD): Idiopathic interstitial pneumonias: UIP,

More information

Diagnostic challenges in IPF

Diagnostic challenges in IPF Medicine, Nursing and Health Sciences Diagnostic challenges in IPF Dr Ian Glaspole Central and Eastern Clinical School, Alfred Hospital and Monash University March 2015 Disclosures Consultancy fees from

More information

Progress in Idiopathic Pulmonary Fibrosis

Progress in Idiopathic Pulmonary Fibrosis Progress in Idiopathic Pulmonary Fibrosis David A. Lynch, MB Disclosures Progress in Idiopathic Pulmonary Fibrosis David A Lynch, MB Consultant: t Research support: Perceptive Imaging Boehringer Ingelheim

More information

11/10/2014. Multi-disciplinary Approach to Diffuse Lung Disease: The Imager s Perspective. Radiology

11/10/2014. Multi-disciplinary Approach to Diffuse Lung Disease: The Imager s Perspective. Radiology Multi-disciplinary Approach to Diffuse Lung Disease: The Imager s Perspective Radiology Pathology Clinical 1 Role of HRCT Diagnosis Fibrosis vs. inflammation Next step in management Response to treatment

More information

5/9/2015. Multi-disciplinary Approach to Diffuse Lung Disease: The Imager s Perspective. No, I am not a pulmonologist! Radiology

5/9/2015. Multi-disciplinary Approach to Diffuse Lung Disease: The Imager s Perspective. No, I am not a pulmonologist! Radiology Multi-disciplinary Approach to Diffuse Lung Disease: The Imager s Perspective No, I am not a pulmonologist! Radiology Pathology Clinical 1 Everyone needs a CT Confidence in diagnosis Definitive HRCT +

More information

Liebow and Carrington's original classification of IIP

Liebow and Carrington's original classification of IIP Liebow and Carrington's original classification of IIP-- 1969 Eric J. Stern MD University of Washington UIP Usual interstitial pneumonia DIP Desquamative interstitial pneumonia BIP Bronchiolitis obliterans

More information

Case 4 History. 58 yo man presented with prox IP joint swelling 2 months later pain and swelling in multiple joints Chest radiograph: bi-basilar

Case 4 History. 58 yo man presented with prox IP joint swelling 2 months later pain and swelling in multiple joints Chest radiograph: bi-basilar Case 4 History 58 yo man presented with prox IP joint swelling 2 months later pain and swelling in multiple joints Chest radiograph: bi-basilar basilar infiltrates suggestive of pulmonary fibrosis Open

More information

Disclosures. Fibrotic lung diseases: Basic Principles, Common Problems, and Reporting. Relevant financial relationships: None. Off-label usage: None

Disclosures. Fibrotic lung diseases: Basic Principles, Common Problems, and Reporting. Relevant financial relationships: None. Off-label usage: None Fibrotic lung diseases: Basic Principles, Common Problems, and Reporting Brandon T. Larsen, MD, PhD Senior Associate Consultant Department of Laboratory Medicine and Pathology Mayo Clinic Arizona Arizona

More information

Unpaid scientific collaborator & advisor with Veracyte, Inc.

Unpaid scientific collaborator & advisor with Veracyte, Inc. Diagnosis and Classification of Idiopathic Interstitial Pneumonias: Role of Histopathology in the Golden Age of Consensus Jeffrey L. Myers, M.D. A. James French Professor of Diagnostic Pathology Vice Chair

More information

Outline Definition of Terms: Lexicon. Traction Bronchiectasis

Outline Definition of Terms: Lexicon. Traction Bronchiectasis HRCT OF IDIOPATHIC INTERSTITIAL PNEUMONIAS Disclosures Genentech, Inc. Speakers Bureau Tadashi Allen, MD University of Minnesota Assistant Professor Diagnostic Radiology 10/29/2016 Outline Definition of

More information

Pathologic Assessment of Interstitial Lung Disease

Pathologic Assessment of Interstitial Lung Disease Pathologic Assessment of Interstitial Lung Disease Dry and itchy? It could be eczema or fungal infection. We don t need to worry, the drugs aren t that dangerous. Kirk D. Jones, MD UCSF Dept. of Pathology

More information

COI: no conflicts of interest to declare

COI: no conflicts of interest to declare Idiopathic versus secondary Usual Interstitial Pneumonia (UIP) pattern in a series of 96 consecutive surgical lung biopsies: The value of histologic ancillary findings in a multidisciplinary discussion

More information

Medical Policy An independent licensee of the Blue Cross Blue Shield Association

Medical Policy An independent licensee of the Blue Cross Blue Shield Association Idiopathic Pulmonary Fibrosis Page 1 of 10 Medical Policy An independent licensee of the Blue Cross Blue Shield Association Title: Idiopathic Pulmonary Fibrosis (Esbriet /pirfenidone, Ofev /nintedanib)

More information

Differential diagnosis

Differential diagnosis Differential diagnosis Idiopathic pulmonary fibrosis (IPF) is part of a large family of idiopathic interstitial pneumonias (IIP), one of four subgroups of interstitial lung disease (ILD). Differential

More information

The radiological differential diagnosis of the UIP pattern

The radiological differential diagnosis of the UIP pattern 5th International Conference on Idiopathic Pulmonary Fibrosis, Modena, 2015, June 12th The radiological differential diagnosis of the UIP pattern Simon Walsh King s College Hospital Foundation Trust London,

More information

Challenges in the Diagnosis of Interstitial Lung Disease

Challenges in the Diagnosis of Interstitial Lung Disease Challenges in the Diagnosis of Interstitial Lung Disease Kirk D. Jones, MD UCSF Dept. of Pathology kirk.jones@ucsf.edu Overview New Classification of IIP Prior classification Modifications for new classification

More information

Guidelines for Diagnosis and Treatment of IPF

Guidelines for Diagnosis and Treatment of IPF Guidelines for Diagnosis and Treatment of IPF Katerina Antoniou, MD, PhD Lecturer in Thoracic Medicine ERS ILD Group Secretary Medical School, University of Crete Classification of Interstitial Lung Disease

More information

Challenges in the Diagnosis of Interstitial Lung Disease

Challenges in the Diagnosis of Interstitial Lung Disease Challenges in the Diagnosis of Interstitial Lung Disease Kirk D. Jones, MD UCSF Dept. of Pathology kirk.jones@ucsf.edu Overview New Classification of IIP Prior classification Modifications for new classification

More information

* * APPROACH TO NON- NEOPLASTIC LUNG DISEASE IN TRANSBRONCHIAL AND SURGICAL BIOPSIES. Financial Disclosures: NONE. BIOPSY TECHNIQUES Bronchoscopic

* * APPROACH TO NON- NEOPLASTIC LUNG DISEASE IN TRANSBRONCHIAL AND SURGICAL BIOPSIES. Financial Disclosures: NONE. BIOPSY TECHNIQUES Bronchoscopic APPROACH TO NON- NEOPLASTIC LUNG DISEASE IN TRANSBRONCHIAL AND SURGICAL BIOPSIES Thomas V. Colby, M.D. Mayo Clinic Arizona Geraldine C. Zeiler Professor of Cytopathology Mayo Clinic Arizona Financial Disclosures:

More information

IPF: Epidemiologia e stato dell arte

IPF: Epidemiologia e stato dell arte IPF: Epidemiologia e stato dell arte Clinical Classification Diffuse parenchimal lung diseases Exposure-related: - occupational - environmental - medication Desquamative interstitial pneumonia Idiopathic

More information

I don t need you. Disclosure Statement. Pathology Approach to ILD 11/5/2016. Kirk D. Jones, MD UCSF Dept of Pathology

I don t need you. Disclosure Statement. Pathology Approach to ILD 11/5/2016. Kirk D. Jones, MD UCSF Dept of Pathology Pathology Approach to ILD Disclosure Statement Relevant financial relationships with a commercial interest: Boeringer Ingleheim, speaker Kirk D. Jones, MD UCSF Dept of Pathology kirk.jones@ucsf.edu I don

More information

Histopathologic Approach to Interstitial Lung Disease

Histopathologic Approach to Interstitial Lung Disease Histopathologic Approach to Interstitial Lung Disease Kirk D. Jones, MD UCSF Dept of Pathology kirk.jones@ucsf.edu Disclosures I have nothing to disclose 1 Why? Much of interstitial lung disease biopsies

More information

Imaging: how to recognise idiopathic pulmonary fibrosis

Imaging: how to recognise idiopathic pulmonary fibrosis REVIEW IDIOPATHIC PULMONARY FIBROSIS Imaging: how to recognise idiopathic pulmonary fibrosis Anand Devaraj Affiliations: Dept of Radiology, St George s Hospital, London, UK. Correspondence: Anand Devaraj,

More information

LUNG BIOPSY IN INTERSTITIAL LUNG DISEASE (ILD) AND THE IMPACT OF TRANSBRONCHIAL CRYOBIOPSY

LUNG BIOPSY IN INTERSTITIAL LUNG DISEASE (ILD) AND THE IMPACT OF TRANSBRONCHIAL CRYOBIOPSY LUNG BIOPSY IN INTERSTITIAL LUNG DISEASE (ILD) AND THE IMPACT OF TRANSBRONCHIAL CRYOBIOPSY Thomas V. Colby MD Professor of Pathology (Emeritus) Mayo Clinic College of Medicine FINANCIAL DISCLOSURES NONE

More information

UPDATE ON INTERSTITIAL LUNG DISEASE. Thomas V. Colby, M.D.

UPDATE ON INTERSTITIAL LUNG DISEASE. Thomas V. Colby, M.D. UPDATE ON INTERSTITIAL LUNG DISEASE Thomas V. Colby, M.D. FINANCIAL DISCLOSURES NONE Topics Discussed 1. Idiopathic pulmonary fibrosis (IPF) 2. Idiopathic interstitial pneumonias (IIPs) 3. Interstitial

More information

INTERSTITIAL LUNG DISEASE. Radhika Reddy MD Pulmonary/Critical Care Long Beach VA Medical Center January 5, 2018

INTERSTITIAL LUNG DISEASE. Radhika Reddy MD Pulmonary/Critical Care Long Beach VA Medical Center January 5, 2018 INTERSTITIAL LUNG DISEASE Radhika Reddy MD Pulmonary/Critical Care Long Beach VA Medical Center January 5, 2018 Interstitial Lung Disease Interstitial Lung Disease Prevalence by Diagnosis: Idiopathic Interstitial

More information

Lung Allograft Dysfunction

Lung Allograft Dysfunction Lung Allograft Dysfunction Carlos S. Restrepo M.D. Ameya Baxi M.D. Department of Radiology University of Texas Health San Antonio Disclaimer: We do not have any conflict of interest or financial gain to

More information

Daria Manos RSNA 2016 RC 401. https://medicine.dal.ca/departments/depar tment-sites/radiology/contact/faculty/dariamanos.html

Daria Manos RSNA 2016 RC 401. https://medicine.dal.ca/departments/depar tment-sites/radiology/contact/faculty/dariamanos.html Daria Manos RSNA 2016 RC 401 https://medicine.dal.ca/departments/depar tment-sites/radiology/contact/faculty/dariamanos.html STEP1: Is this fibrotic lung disease? STEP 2: Is this a UIP pattern? If yes:

More information

An earlier and more confident diagnosis of idiopathic pulmonary fibrosis

An earlier and more confident diagnosis of idiopathic pulmonary fibrosis Eur Respir Rev 2012; 21: 124, 141 146 DOI: 10.1183/09059180.00000812 CopyrightßERS 2012 REVIEW: IPF An earlier and more confident diagnosis of idiopathic pulmonary fibrosis Roland M. du Bois ABSTRACT:

More information

IPF - Inquadramento clinico

IPF - Inquadramento clinico IPF - Inquadramento clinico Sergio Harari Unità Operativa di Pneumologia UTIR Servizio di Fisiopat. Resp. e Emodinamica Polmonare Ospedale S. Giuseppe, Milano Clinical Classification Diffuse parenchimal

More information

Financial disclosure COMMON DIAGNOSES IN HRCT. High Res Chest HRCT. HRCT Pre test. I have no financial relationships to disclose. Anatomy Nomenclature

Financial disclosure COMMON DIAGNOSES IN HRCT. High Res Chest HRCT. HRCT Pre test. I have no financial relationships to disclose. Anatomy Nomenclature Financial disclosure I have no financial relationships to disclose. Douglas Johnson D.O. Cardiothoracic Imaging Gaston Radiology COMMON DIAGNOSES IN HRCT High Res Chest Anatomy Nomenclature HRCT Sampling

More information

A Review of Interstitial Lung Diseases. Paul J. Wolters, MD Associate Professor Department of Medicine University of California San Francisco

A Review of Interstitial Lung Diseases. Paul J. Wolters, MD Associate Professor Department of Medicine University of California San Francisco A Review of Interstitial Lung Diseases Paul J. Wolters, MD Associate Professor Department of Medicine University of California San Francisco Outline Overview of diagnosis in ILD Why it is important Definition/Classification

More information

CTD-related Lung Disease

CTD-related Lung Disease 13 th Cambridge Chest Meeting King s College, Cambridge April 2015 Imaging of CTD-related Lung Disease Dr Sujal R Desai King s College Hospital, London Disclosure Statement No Disclosures / Conflicts of

More information

Hypersensitivity Pneumonitis: Spectrum of High-Resolution CT and Pathologic Findings

Hypersensitivity Pneumonitis: Spectrum of High-Resolution CT and Pathologic Findings CT of Hypersensitivity Pneumonitis Chest Imaging Pictorial Essay C. Isabela S. Silva 1 ndrew Churg 2 Nestor L. Müller 1 Silva CIS, Churg, Müller NL Keywords: high-resolution CT, hypersensitivity pneumonitis,

More information

Summary: Key Learning Points, Clinical Strategies, and Future Directions

Summary: Key Learning Points, Clinical Strategies, and Future Directions Summary: Key Learning Points, Clinical Strategies, and Future Directions Introduction Idiopathic pulmonary fibrosis (IPF), a peripheral lobular fibrosis of unknown cause, is a chronic, progressive lung

More information

Connective Tissue Disorder- Associated Interstitial Lung Disease (CTD-ILD) and Updates

Connective Tissue Disorder- Associated Interstitial Lung Disease (CTD-ILD) and Updates Connective Tissue Disorder- Associated Interstitial Lung Disease (CTD-ILD) and Updates Maria Elena Vega, M.D Assistant Professor of Medicine Lewis Katz School of Medicine at Temple University Nothing to

More information

Idiopathic Pulmonary of Care

Idiopathic Pulmonary of Care Chapter 6.1 Living Medical etextbook A Digital Tool at the Point of Care From Projects In Knowledge Pulmonology Idiopathic Pulmonary Fibrosis @Point of Care IPF Case Study: Typical Presentation, Role of

More information

Diffuse Interstitial Lung Diseases: Is There Really Anything New?

Diffuse Interstitial Lung Diseases: Is There Really Anything New? : Is There Really Anything New? Sujal R. Desai, MBBS, MD ESTI SPEAKER SUNDAY Society of Thoracic Radiology San Antonio, Texas March 2014 Diffuse Interstitial Lung Disease The State of Play DILDs Is There

More information

A Review of Interstitial Lung Diseases

A Review of Interstitial Lung Diseases Outline A Review of Interstitial Lung Diseases Paul J. Wolters, MD Associate Professor Department of Medicine University of California San Francisco Overview of diagnosis in ILD Why it is important Definition/Classification

More information

Idiopathic interstitial pneumonias (IIPs) are a group of

Idiopathic interstitial pneumonias (IIPs) are a group of SYMPOSIA C. Isabela S. Silva, MD, PhD and Nestor L. Müller, MD, PhD Abstract: The idiopathic interstitial pneumonias (IIPs) are a group of diffuse parenchymal lung diseases of unknown etiology characterized

More information

Overview of Idiopathic Pulmonary Fibrosis: Diagnosis and Therapy

Overview of Idiopathic Pulmonary Fibrosis: Diagnosis and Therapy Overview of Idiopathic Pulmonary Fibrosis: Diagnosis and Therapy Jeff Swigris, DO, MS Director, ILD Program National Jewish Health Disclosures Speaker - Boehringer Ingelheim and Genentech Objectives Describe

More information

HRCT in Diffuse Interstitial Lung Disease Steps in High Resolution CT Diagnosis. Where are the lymphatics? Anatomic distribution

HRCT in Diffuse Interstitial Lung Disease Steps in High Resolution CT Diagnosis. Where are the lymphatics? Anatomic distribution Steps in High Resolution CT Diagnosis Pattern of abnormality Distribution of disease Associated findings Clinical history Tomás Franquet MD What is the diagnosis? Hospital de Sant Pau. Barcelona Secondary

More information

Difficulties Diagnosing Idiopathic Pulmonary Fibrosis

Difficulties Diagnosing Idiopathic Pulmonary Fibrosis 1. er Encuentro Entre Neumólogos y Radiólogos, Madrid, Spain, 2016, October 14th Difficulties Diagnosing Idiopathic Pulmonary Fibrosis Simon Walsh King s College Hospital Foundation Trust London, United

More information

Manish Powari Regional Training Day 10/12/2014

Manish Powari Regional Training Day 10/12/2014 Manish Powari Regional Training Day 10/12/2014 Large number of different types of Interstitial Lung Disease (ILD). Most are very rare Most patients present with one of a smaller number of commoner diseases

More information

Update on Pulmonary Fibrosis

Update on Pulmonary Fibrosis Update on Pulmonary Fibrosis Not All Fibrosis Is Created Equally Maxwell L. Smith, MD Context. Three distinct patterns of pulmonary fibrosis, including usual interstitial pneumonia, fibrotic nonspecific

More information

Bronkhorst colloquium Interstitiële longziekten. Katrien Grünberg, klinisch patholoog

Bronkhorst colloquium Interstitiële longziekten. Katrien Grünberg, klinisch patholoog Bronkhorst colloquium 2013-2014 Interstitiële longziekten De pathologie achter de CT Katrien Grünberg, klinisch patholoog K.grunberg@vumc.nl Preparing: introduction and 3 cases The introduction on microscopic

More information

Case Presentations in ILD. Harold R. Collard, MD Department of Medicine University of California San Francisco

Case Presentations in ILD. Harold R. Collard, MD Department of Medicine University of California San Francisco Case Presentations in ILD Harold R. Collard, MD Department of Medicine University of California San Francisco Outline Overview of diagnosis in ILD Definition/Classification High-resolution CT scan Multidisciplinary

More information

Cryptogenic Organizing Pneumonia Diagnosis Approach Based on a Clinical-Radiologic-Pathologic Consensus

Cryptogenic Organizing Pneumonia Diagnosis Approach Based on a Clinical-Radiologic-Pathologic Consensus Cryptogenic Organizing Pneumonia Diagnosis Approach Based on a Clinical-Radiologic-Pathologic Consensus Poster No.: C-1622 Congress: ECR 2012 Type: Scientific Exhibit Authors: C. Cordero Lares, E. Zorita

More information

CT in Idiopathic Pulmonary Fibrosis: Diagnosis and Beyond

CT in Idiopathic Pulmonary Fibrosis: Diagnosis and Beyond Cardiopulmonary Imaging Review Gruden CT of Idiopathic Pulmonary Fibrosis Cardiopulmonary Imaging Review James F. Gruden 1 Gruden JF FOCUS ON: Keywords: CT, diagnosis, high-resolution CT, idiopathic pulmonary

More information

UIP Possibile e Probabile

UIP Possibile e Probabile UIP Possibile e Probabile Sergio Harari U.O. di Pneumologia e UTIR Servizio di Emodinamica e Fisiopatologia Respiratoria Ospedale San Giuseppe - Milano Current definition of IPF IPF is a distinct type

More information

Radiologic Approach to Smoking Related Interstitial Lung Disease

Radiologic Approach to Smoking Related Interstitial Lung Disease Radiologic Approach to Smoking Related Interstitial Lung Disease Poster No.: C-1854 Congress: ECR 2013 Type: Educational Exhibit Authors: K.-N. Lee, J.-Y. Han, E.-J. Kang, J. Kang; Busan/KR Keywords: Toxicity,

More information

Hypersensitivity Pneumonitis Common Diagnostic and Treatment Dilemmas

Hypersensitivity Pneumonitis Common Diagnostic and Treatment Dilemmas Hypersensitivity Pneumonitis Common Diagnostic and Treatment Dilemmas Rishi Raj MD Director, Interstitial Lung Diseases Program Clinical Professor of Pulmonary and Critical Care Medicine Stanford University

More information

Acute and Chronic Lung Disease

Acute and Chronic Lung Disease KATHOLIEKE UNIVERSITEIT LEUVEN Faculty of Medicine Acute and Chronic Lung Disease W De Wever, JA Verschakelen Department of Radiology, University Hospitals Leuven, Belgium Clinical utility of HRCT To detect

More information

Diagnosing Idiopathic Pulmonary Fibrosis on Evidence-Based Guidelines

Diagnosing Idiopathic Pulmonary Fibrosis on Evidence-Based Guidelines Diagnosing Idiopathic Pulmonary Fibrosis on Evidence-Based Guidelines Rebecca Keith, MD Assistant Professor, Division of Pulmonary and Critical Care Medicine National Jewish Health, Denver, CO Objectives

More information

Diagnostic criteria for Idiopathic Pulmonary Fibrosis: a Fleischner Society White Paper

Diagnostic criteria for Idiopathic Pulmonary Fibrosis: a Fleischner Society White Paper Diagnostic criteria for Idiopathic Pulmonary Fibrosis: a Fleischner Society White Paper David A Lynch, MB Nicola Sverzellati, MD William D Travis, MD Kevin K Brown, MD Thomas V Colby, MD Jeffrey R Galvin,

More information

DIAGNOSTIC NOTE TEMPLATE

DIAGNOSTIC NOTE TEMPLATE DIAGNOSTIC NOTE TEMPLATE SOAP NOTE TEMPLATE WHEN CONSIDERING A DIAGNOSIS OF IDIOPATHIC PULMONARY FIBROSIS (IPF) CHIEF COMPLAINT HISTORY OF PRESENT ILLNESS Consider IPF as possible diagnosis if any of the

More information

International consensus statement on idiopathic pulmonary fibrosis

International consensus statement on idiopathic pulmonary fibrosis Eur Respir J 2001; 17: 163 167 Printed in UK all rights reserved Copyright #ERS Journals Ltd 2001 European Respiratory Journal ISSN 0903-1936 PERSPECTIVE International consensus statement on idiopathic

More information

June 2013 Pulmonary Case of the Month: Diagnosis Makes a Difference. Lewis J. Wesselius, MD 1 Henry D. Tazelaar, MD 2

June 2013 Pulmonary Case of the Month: Diagnosis Makes a Difference. Lewis J. Wesselius, MD 1 Henry D. Tazelaar, MD 2 June 2013 Pulmonary Case of the Month: Diagnosis Makes a Difference Lewis J. Wesselius, MD 1 Henry D. Tazelaar, MD 2 Departments of Pulmonary Medicine 1 and Laboratory Medicine and Pathology 2 Mayo Clinic

More information

Katerina M. Antoniou, MD, PhD As. Professor in Thoracic Medicine ERS ILD Group Secretary Medical School, University of Crete Prague, June 2014

Katerina M. Antoniou, MD, PhD As. Professor in Thoracic Medicine ERS ILD Group Secretary Medical School, University of Crete Prague, June 2014 Hypersensitivity pneumonitis: Causes, clinical course, diagnosis and differential diagnosis, treatment Katerina M. Antoniou, MD, PhD As. Professor in Thoracic Medicine ERS ILD Group Secretary Medical School,

More information

Monday 10 September Interstitial lung disease 15:10 15:35. The uncommon interstitial lung diseases (ILD)

Monday 10 September Interstitial lung disease 15:10 15:35. The uncommon interstitial lung diseases (ILD) Interstitial lung disease 15:10 15:35 The uncommon interstitial lung diseases (ILD) Dr Grant Griffiths, Cwm Taf University Health Board, Cardiff Be familiar with the Diagnostic criteria for idiopathic

More information

The Egyptian Journal of Hospital Medicine (July 2017) Vol.68 (2), Page

The Egyptian Journal of Hospital Medicine (July 2017) Vol.68 (2), Page The Egyptian Journal of Hospital Medicine (July 2017) Vol.68 (2), Page 1135-1140 Role of High Resolution Computed Tomography in Diagnosis of Interstitial Lung Diseases in Patients with Collagen Diseases

More information

Nonspecific interstitial pneumonia and usual interstitial pneumonia: comparison of the clinicopathologic features and prognosis

Nonspecific interstitial pneumonia and usual interstitial pneumonia: comparison of the clinicopathologic features and prognosis Original Article Nonspecific interstitial pneumonia and usual interstitial pneumonia: comparison of the clinicopathologic features and prognosis Xia Li 1, Chang Chen 2, Jinfu Xu 1, Jinming Liu 1, Xianghua

More information

TBLB is not recommended as the initial biopsy option in cases of suspected IPF and is unreliable in the diagnosis of rare lung disease (other than

TBLB is not recommended as the initial biopsy option in cases of suspected IPF and is unreliable in the diagnosis of rare lung disease (other than TBLB is not recommended as the initial biopsy option in cases of suspected IPF and is unreliable in the diagnosis of rare lung disease (other than PAP) BAL is not required as a diagnostic tool in patients

More information

T he diagnostic evaluation of a patient with

T he diagnostic evaluation of a patient with 546 REVIEW SERIES Challenges in pulmonary fibrosis? 1: Use of high resolution CT scanning of the lung for the evaluation of patients with idiopathic interstitial pneumonias Michael B Gotway, Michelle M

More information

Imaging findings in Hypersensitivity Pneumonitis - a pictorical review.

Imaging findings in Hypersensitivity Pneumonitis - a pictorical review. Imaging findings in Hypersensitivity Pneumonitis - a pictorical review. Poster No.: C-1655 Congress: ECR 2014 Type: Educational Exhibit Authors: B. M. Araujo, A. F. S. Simões, M. S. C. Rodrigues, J. Pereira;

More information

Radiologic pathologic discordance in biopsy-proven usual interstitial pneumonia

Radiologic pathologic discordance in biopsy-proven usual interstitial pneumonia ERJ Express. Published on February 25, 2016 as doi: 10.1183/13993003.01680-2015 ORIGINAL ARTICLE IN PRESS CORRECTED PROOF Radiologic pathologic discordance in biopsy-proven usual interstitial pneumonia

More information

Pathology of Chronic Hypersensitivity Pneumonitis. What Is It? What Are the Diagnostic Criteria? Why Do We Care?

Pathology of Chronic Hypersensitivity Pneumonitis. What Is It? What Are the Diagnostic Criteria? Why Do We Care? Pathology of Chronic Hypersensitivity Pneumonitis What Is It? What Are the Diagnostic Criteria? Why Do We Care? Andrew Churg, MD; AnaMaria Bilawich, MD; Joanne L. Wright, MD Context. Chronic hypersensitivity

More information

Epidemiology and classification of smoking related interstitial lung diseases

Epidemiology and classification of smoking related interstitial lung diseases Epidemiology and classification of smoking related interstitial lung diseases Šterclová M. Department of Respiratory Diseases, Thomayer Hospital, Prague, Czech Republic Supported by an IGA Grant No G 1207

More information

4/17/2010 C ini n ca c l a Ev E a v l a ua u t a ion o n of o ILD U dat a e t e i n I LDs

4/17/2010 C ini n ca c l a Ev E a v l a ua u t a ion o n of o ILD U dat a e t e i n I LDs Update in ILDs Diagnosis 101: Clinical Evaluation April 17, 2010 Jay H. Ryu, MD Mayo Clinic, Rochester MN Clinical Evaluation of ILD Outline General aspects of ILDs Classification of ILDs Clinical evaluation

More information

Diagnostic Approach to Advanced Fibrotic Interstitial Lung Disease. Bringing Together Clinical, Radiologic, and Histologic Clues

Diagnostic Approach to Advanced Fibrotic Interstitial Lung Disease. Bringing Together Clinical, Radiologic, and Histologic Clues Diagnostic Approach to Advanced Fibrotic Interstitial Lung Disease Bringing Together Clinical, Radiologic, and Histologic Clues Brandon T. Larsen, MD, PhD; Maxwell L. Smith, MD; Brett M. Elicker, MD; Jessica

More information

Smoking-related Interstitial Lung Diseases: High-Resolution CT Findings

Smoking-related Interstitial Lung Diseases: High-Resolution CT Findings Smoking-related Interstitial Lung Diseases: High-Resolution CT Findings Poster No.: C-2358 Congress: ECR 2013 Type: Educational Exhibit Authors: V. Cuartero Revilla, M. Nogueras Carrasco, P. Olmedilla

More information

Bronchoalveolar Lavage and Histopathologic Diagnosis Based on Biopsy

Bronchoalveolar Lavage and Histopathologic Diagnosis Based on Biopsy Idiopathic Pulmonary Fibrosis Bronchoalveolar Lavage and Histopathologic Diagnosis Based on Biopsy JMAJ 46(11): 469 474, 2003 Yukihiko SUGIYAMA Professor, Division of Pulmonary Medicine, Department of

More information

Imaging Small Airways Diseases: Not Just Air trapping. Eric J. Stern MD University of Washington

Imaging Small Airways Diseases: Not Just Air trapping. Eric J. Stern MD University of Washington Imaging Small Airways Diseases: Not Just Air trapping Eric J. Stern MD University of Washington What we are discussing SAD classification SAD imaging with MDCT emphasis What is a small airway? Airway with

More information

Thoracic lung involvement in rheumatoid arthritis: Findings on HRCT

Thoracic lung involvement in rheumatoid arthritis: Findings on HRCT Thoracic lung involvement in rheumatoid arthritis: Findings on HRCT Poster No.: C-2488 Congress: ECR 2015 Type: Educational Exhibit Authors: R. E. Correa Soto, M. J. Martín Sánchez, J. M. Fernandez 1 1

More information

Idiopathic Pulmonary Fibrosis Treatable and Not Idiopathic

Idiopathic Pulmonary Fibrosis Treatable and Not Idiopathic Idiopathic Pulmonary Fibrosis Treatable and Not Idiopathic Brett Ley, MD University of California San Francisco CTS 1/26/18 Disclosures Speaker s bureau honorarium from Genentech (makers of pirfenidone)

More information

Criteria for confident HRCT diagnosis of usual interstitial pneumonia (UIP)

Criteria for confident HRCT diagnosis of usual interstitial pneumonia (UIP) Criteria for confident HRCT diagnosis of usual interstitial pneumonia (UIP) Assem El Essawy (1) & Amr A. Nassef (٢) Abstract Identification of interstitial pneumonia (IP) was mainly based on histological

More information

Combined Unclassifiable Interstitial Pneumonia and Emphysema: A Report of Two Cases

Combined Unclassifiable Interstitial Pneumonia and Emphysema: A Report of Two Cases CASE REPORT Combined Unclassifiable Interstitial Pneumonia and Emphysema: A Report of Two Cases Nobuhiko Nagata 1, Kentaro Watanabe 2, Michihiro Yoshimi 3, Hiroshi Okabayashi 4, Katsuo Sueishi 5, Kentaro

More information

Prognostic Significance of Histopathologic Subsets in Idiopathic Pulmonary Fibrosis

Prognostic Significance of Histopathologic Subsets in Idiopathic Pulmonary Fibrosis Prognostic Significance of Histopathologic Subsets in Idiopathic Pulmonary Fibrosis JULIE A. BJORAKER, JAY H. RYU, MARK K. EDWIN, JEFFREY L. MYERS, HENRY D. TAZELAAR, DARRELL R. SCHROEDER, and KENNETH

More information

Pulmonary manifestations of CTDs Diagnosis, differential diagnosis and treatment

Pulmonary manifestations of CTDs Diagnosis, differential diagnosis and treatment Prague, June 2014 Pulmonary manifestations of CTDs Diagnosis, differential diagnosis and treatment Katerina M. Antoniou, MD, PhD As. Professor in Thoracic Medicine ERS ILD Group Secretary Medical School,

More information

Replacement of air with fluid, inflammatory. cells or cellular debris. Parenchymal, Interstitial (Restrictive) and Vascular Diseases.

Replacement of air with fluid, inflammatory. cells or cellular debris. Parenchymal, Interstitial (Restrictive) and Vascular Diseases. Parenchymal, Interstitial (Restrictive) and Vascular Diseases Alain C. Borczuk, M.D. Dept of Pathology Replacement of air with fluid, inflammatory cells Pulmonary Edema Pneumonia Hemorrhage Diffuse alveolar

More information

HYPERSENSITIVITY PNEUMONITIS

HYPERSENSITIVITY PNEUMONITIS HYPERSENSITIVITY PNEUMONITIS A preventable fibrosis MOSAVIR ANSARIE MB., FCCP INTERSTITIAL LUNG DISEASES A heterogeneous group of non infectious, non malignant diffuse parenchymal disorders of the lower

More information

Lines and crackles. Making sense of ILD

Lines and crackles. Making sense of ILD Lines and crackles Making sense of ILD Case JM 65 year old male Gradual shortness of breath, going on over a year Some dry cough Ex-smoker, quit 10 years ago Crackles in the bases CXR presented Sent to

More information

Diagnosing ILD. What is important in 2016? Chris Grainge

Diagnosing ILD. What is important in 2016? Chris Grainge Diagnosing ILD What is important in 2016? Chris Grainge Senior Staff Specialist Respiratory Medicine John Hunter Hospital Conjoint A/Prof University of Newcastle Conflict of interest I have acted as a

More information

The crazy-paving pattern: A radiological-pathological correlated and illustrated overview

The crazy-paving pattern: A radiological-pathological correlated and illustrated overview The crazy-paving pattern: A radiological-pathological correlated and illustrated overview Poster No.: C-0827 Congress: ECR 2010 Type: Educational Exhibit Topic: Chest Authors: W. F. M. De Wever, J. Coolen,

More information

PFF HEALTH CARE PROFESSIONAL WEBINAR SERIES. Welcome!

PFF HEALTH CARE PROFESSIONAL WEBINAR SERIES. Welcome! PFF HEALTH CARE PROFESSIONAL WEBINAR SERIES Welcome! AGENDA TOPICS Welcome & Introduction Dr. Gregory Cosgrove, MD Chief Medical Officer Pulmonary Fibrosis Foundation PFF Resources Dolly Kervitsky, RCP,

More information

Restrictive lung diseases

Restrictive lung diseases Restrictive lung diseases Restrictive lung diseases are diseases that affect the interstitium of the lung. Interstitium of the lung is the very thin walls surrounding the alveoli, it s formed of epithelium

More information

ESBRIET (pirfenidone) oral capsule and oral tablet OFEV (nintedanib) oral capsule

ESBRIET (pirfenidone) oral capsule and oral tablet OFEV (nintedanib) oral capsule OFEV (nintedanib) oral capsule Coverage for services, procedures, medical devices and drugs are dependent upon benefit eligibility as outlined in the member's specific benefit plan. This Pharmacy Coverage

More information

National Jewish Health. Idiopathic Pulmonary Fibrosis: A Guide for Providers

National Jewish Health. Idiopathic Pulmonary Fibrosis: A Guide for Providers National Jewish Health Idiopathic Pulmonary Fibrosis: A Guide for Providers Table of Contents National Jewish Health Materials were developed through a partnership between National Jewish Health and PVI,

More information

Systemic lupus erythematosus (SLE): Pleuropulmonary Manifestations

Systemic lupus erythematosus (SLE): Pleuropulmonary Manifestations 08/30/10 09/26/10 Systemic lupus erythematosus (SLE): Pleuropulmonary Manifestations Camila Downey S. Universidad de Chile, School of Medicine, Year VII Harvard University, School of Medicine Sept 17,

More information

DIFFERENCES IN FIBROPROLIFERATIVE HEALING IN EXOGENEOUS AND IDIOPATHIC ILDs. ARE THERE ANY?

DIFFERENCES IN FIBROPROLIFERATIVE HEALING IN EXOGENEOUS AND IDIOPATHIC ILDs. ARE THERE ANY? NIHR Southampton Respiratory Biomedical Research Unit DIFFERENCES IN FIBROPROLIFERATIVE HEALING IN EXOGENEOUS AND IDIOPATHIC ILDs. ARE THERE ANY? Fibrosing Interstitial Lung Diseases CPFS/WASOG/AIPO/ERS

More information

How to identify interstitial pneumonias.

How to identify interstitial pneumonias. How to identify interstitial pneumonias. Poster No.: C-0804 Congress: ECR 2014 Type: Educational Exhibit Authors: S. claret loaiza, M. C. Cañete Moslero, R. Carreño Gonzalez, C. de la Torre; Malaga/ES

More information

Histopathology of Explanted Lungs from Patients with a Diagnosis of Pulmonary. Sarcoidosis MD 4

Histopathology of Explanted Lungs from Patients with a Diagnosis of Pulmonary. Sarcoidosis MD 4 1 Word count: 241 (abstract) and 2499(text) 2 3 4 Histopathology of Explanted Lungs from Patients with a Diagnosis of Pulmonary Sarcoidosis 5 6 Chen Zhang, MD, PhD 1, Kevin M. Chan, MD 2, Lindsay A. Schmidt,

More information

Conflicts of Interest. Advisory Board: Boehringer-Ingleheim, Genentech/Roche DSMB: Bristol-Myers Squibb, Fibrogen Clinical Endpoint Committee; Merck

Conflicts of Interest. Advisory Board: Boehringer-Ingleheim, Genentech/Roche DSMB: Bristol-Myers Squibb, Fibrogen Clinical Endpoint Committee; Merck Conflicts of Interest Advisory Board: Boehringer-Ingleheim, Genentech/Roche DSMB: Bristol-Myers Squibb, Fibrogen Clinical Endpoint Committee; Merck The Idiopathic Interstitial Pneumonias Idiopathic pulmonary

More information

Key words: CT scanners; interstitial lung diseases; polymyositis-dermatomyositis; x-ray

Key words: CT scanners; interstitial lung diseases; polymyositis-dermatomyositis; x-ray Nonspecific Interstitial Pneumonia Associated With Polymyositis and Dermatomyositis* Serial High-Resolution CT Findings and Functional Correlation Hiroaki Arakawa, MD; Hidehiro Yamada, MD; Yasuyuki Kurihara,

More information

A case of a patient with IPF treated with nintedanib. Prof. Kreuter and Prof. Heussel

A case of a patient with IPF treated with nintedanib. Prof. Kreuter and Prof. Heussel A case of a patient with IPF treated with nintedanib Prof. Kreuter and Prof. Heussel Case Overview This case describes the history of a patient with IPF who, at the time of diagnosis, had symptoms typical

More information

ARTICLE IN PRESS. Ahuva Grubstein a, Daniele Bendayan b, Ithak Schactman c, Maya Cohen a, David Shitrit b, Mordechai R. Kramer b,

ARTICLE IN PRESS. Ahuva Grubstein a, Daniele Bendayan b, Ithak Schactman c, Maya Cohen a, David Shitrit b, Mordechai R. Kramer b, Respiratory Medicine (2005) 99, 948 954 Concomitant upper-lobe bullous emphysema, lower-lobe interstitial fibrosis and pulmonary hypertension in heavy smokers: report of eight cases and review of the literature

More information

IPF AND OTHER FIBROSING LUNG DISEASE: WHAT DRUGS MIGHT WORK AND ON WHOM DO THEY W ORK?

IPF AND OTHER FIBROSING LUNG DISEASE: WHAT DRUGS MIGHT WORK AND ON WHOM DO THEY W ORK? IPF AND OTHER FIBROSING LUNG DISEASE: WHAT DRUGS MIGHT WORK AND ON WHOM DO THEY W ORK? KEVIN K. BROWN, MD PROFESSOR AND VICE CHAIRMAN, DEPARTMENT OF MEDICINE NATIONAL JEWISH HEALTH DENVER, CO Kevin K.

More information

Parenchymal, Interstitial i (Restrictive) i and Vascular Diseases

Parenchymal, Interstitial i (Restrictive) i and Vascular Diseases Pulmonary Diseases: Structure-Function Correlation II Parenchymal, Interstitial i (Restrictive) i and Vascular Diseases Alain C. Borczuk, M.D. Dept of Pathology Pulmonary Diseases: Structure-Function Correlation

More information